Amsterdam-based healthtech with a personalized digital type 2 diabetes remission program.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Funding round Clear.bio raised €1.7 million from Horizon Flevoland, Future Food Fund and Invest International for its digital program against type 2 diabetes. | $2M |
| Nov 2022 | Seed Amsterdam-based healthtech Clear.bio raised an undisclosed round from Achmea Innovation Fund, with existing investors Future Food Fund and Antler participating. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.